UPAR and cathepsin B inhibition enhanced radiation-induced apoptosis in gliomainitiating cells

Neuro-Oncology

Volumn 14, Issue 6, 2012, Pages 745-760

  Malla, Rama Rao ^a   Gopinath, Sreelatha ^a   Alapati, Kiranmai ^a   Gorantla, Bharathi ^a   Gondi, Christopher S ^a   Rao, Jasti S ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

apoptosis; gH2AX; glioma initiating cells; radiation

Indexed keywords

CATHEPSIN B; CD133 ANTIGEN; HISTONE H2AX; NESTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; SCATTER FACTOR RECEPTOR; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; SURVIVIN; TRANSCRIPTION FACTOR SOX2; TUJ 1 PROTEIN; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL SELECTION; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; GENE SILENCING; GLIOMA CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; RADIATION DOSE; RADIATION INJURY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CATHEPSIN B; CELL CYCLE; CELL LINE, TUMOR; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; IN SITU NICK-END LABELING; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

EID: 84862200200     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos088     Document Type: Article

References (59)

1. Legler JM, Ries LA, Smith MA, et al. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst. 1999;91: 1382-1390. (Pubitemid 29399996)
2. Garden AS, Maor MH, Yung WK, et al. Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol. 1991;20:99-110.
3. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756-760. (Pubitemid 44949604)
4. Bexell D, Scheding S, Bengzon J. Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors. Mol Ther. 2010;18:1067-1075.
5. Henson PM, Hume DA. Apoptotic cell removal in development and tissue homeostasis. Trends Immunol. 2006;27:244-250.
6. Clement V, Dutoit V, Marino D, Dietrich PY, Radovanovic I. Limits of CD133 as a marker of glioma self-renewing cells. Int J Cancer. 2009;125:244-248.
7. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577-580. (Pubitemid 28067289)
8. Bassing CH, Suh H, Ferguson DO, et al. Histone H2AX: a dosagedependent suppressor of oncogenic translocations and tumors. Cell. 2003;114:359-370. (Pubitemid 36962934)
9. Celeste A, Difilippantonio S, Difilippantonio MJ, et al. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell. 2003;114:371-383. (Pubitemid 36962935)
10. Celeste A, Petersen S, Romanienko PJ, et al. Genomic instability in mice lacking histone H2AX. Science. 2002;296:922-927. (Pubitemid 34464900)
11. Ismail IH, Hendzel MJ. The gamma-H2A.X: is it just a surrogate marker of double-strand breaks or much more? Environ Mol Mutagen. 2008;49:73-82. (Pubitemid 351293013)
12. Liu Y, Tseng M, Perdreau SA, et al. Histone H2AX is a mediator of gastrointestinal stromal tumor cell apoptosis following treatment with imatinib mesylate. Cancer Res. 2007;67:2685-2692. (Pubitemid 46548956)
13. Solovjeva LV, Svetlova MP, Chagin VO, Tomilin NV. Inhibition of transcription at radiation-induced nuclear foci of phosphorylated histone H2AX in mammalian cells. Chromosome Res. 2007;15:787-797. (Pubitemid 47415802)
14. Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403:41-45. (Pubitemid 30038513)
15. Ku JH, Kwak C, Lee HS, Park HK, Lee E, Lee SE. Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder. J Urol. 2004;171:631-635. (Pubitemid 38090445)
16. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 1998;17:3247-3259. (Pubitemid 29043977)
17. Cheung WL, Albadine R, Chan T, Sharma R, Netto GJ. Phosphorylated H2AX in noninvasive low grade urothelial carcinoma of the bladder: correlation with tumor recurrence. J Urol. 2009;181:1387-1392.
18. Smith HW, Marshall CJ. Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol. 2010;11:23-36.
19. Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol. 2002;3:932-943. (Pubitemid 35477371)
20. Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer. 2003;3:489-501. (Pubitemid 37328837)
21. Sivaparvathi M, Sawaya R, Wang SW, et al. Overexpression and localization of cathepsin B during the progression of human gliomas. Clin Exp Metastasis. 1995;13:49-56.
22. Yamamoto M, Sawaya R, Mohanam S, et al. Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. Cancer Res. 1994;54:5016-5020. (Pubitemid 24289437)
23. Jo M, Eastman BM,Webb DL, Stoletov K, Klemke R, Gonias SL. Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells. Cancer Res. 2010;70:8948-8958.
24. Strojnik T, Rosland GV, Sakariassen PO, Kavalar R, Lah T. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol. 2007;68:133-143. (Pubitemid 47087905)
25. Malla R, Gopinath S, Alapati K, et al. Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas. PLoS One. 2010;5:e13731.
26. Yuan X, Curtin J, Xiong Y, et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene. 2004;23:9392-9400. (Pubitemid 40069671)
27. Gondi CS, Kandhukuri N, Kondraganti S, et al. Down-regulation of uPAR and cathepsin B retards cofilin dephosphorylation. Int J Oncol. 2006;28:633-639.
28. Malla RR, Gopinath S, Gondi CS, et al. Cathepsin B and uPAR knockdown inhibits tumor-induced angiogenesis by modulating VEGF expression in glioma. Cancer Gene Ther. 2011;18:419-434.
29. Gopinath S, Malla RR, Gondi CS, et al. Co-depletion of cathepsin B and uPAR induces G0/G1 arrest in glioma via FOXO3a mediated p27 upregulation. PLoS One. 2010;5:e11668.
30. Altaner C. Glioblastoma and stem cells. Neoplasma. 2008;55:369-374.
31. Naidu MD, Mason JM, Pica RV, Fung H, Pena LA. Radiation resistance in glioma cells determined by DNA damage repair activity of Ape1/Ref-1. J Radiat Res (Tokyo). 2010;51:393-404.
32. Gupta R, Nalla AK, Gogineni VR, et al. uPAR/cathepsin B overexpression reverse angiogenesis by rescuing FAK phosphorylation in uPAR/cathepsin B down regulated meningioma. PLoS One. 2011;6:e17123.
33. Leskov KS, Criswell T, Antonio S, et al. When X-ray-inducible proteins meet DNA double strand break repair. Semin Radiat Oncol. 2001;11:352-372. (Pubitemid 32959670)
34. Huang X, Halicka HD, Darzynkiewicz Z. Detection of histone H2AX phosphorylation on Ser-139 as an indicator of DNA damage (DNA double-strand breaks). Curr Protoc Cytom. 2004;7:27.
35. Steger DJ,Workman JL. Transcriptional analysis of purified histone acetyltransferase complexes. Methods. 1999;19:410-416.
36. Chakravarti A, Zhai GG, Zhang M, et al. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene. 2004;23:7494-7506. (Pubitemid 39389691)
37. Li Y, Li A, Glas M, et al. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proc Natl Acad Sci USA. 2011;108:9951-9956.
38. Moriyama T, Kataoka H, Hamasuna R, et al. Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells. Clin Exp Metastasis. 1999;17:873-879.
39. Singh SK, Clarke ID, Hide T, Dirks PB. Cancer stem cells in nervous system tumors. Oncogene. 2004;23:7267-7273. (Pubitemid 39382160)
40. Liu G, Yuan X, Zeng Z, et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer. 2006;5:67.
41. Badiga AV, Chetty C, Kesanakurti D, et al. MMP-2 siRNA Inhibits Radiation-Enhanced Invasiveness in Glioma Cells. PLoS One. 2011;6:e20614.
42. Ganji PC, Nalla AK, Gupta R, et al. siRNA-Mediated Downregulation of MMP-9 and uPAR in Combination with Radiation Induces G2/M Cell-Cycle Arrest in Medulloblastoma. Mol Cancer Res. 2011;9:51-66.
43. Firat E, Gaedicke S, Tsurumi C, Esser N, Weyerbrock A, Niedermann G. Delayed cell death associated with mitotic catastrophe in gamma-irradiated stem-like glioma cells. Radiat Oncol. 2011;6:71.:71.
44. Gondi CS, Lakka SS, Dinh D, Olivero W, Gujrati M, Rao JS. Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth. Neuron Glia Biology. 2004;1:165-176.
45. Gondi CS, Lakka SS, Dinh DH, Olivero WC, Gujrati M, Rao JS. RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene. 2004;23:8486-8496. (Pubitemid 39540799)
46. Kim IA, Bae SS, Fernandes A, et al. Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines. Cancer Res. 2005;65:7902-7910. (Pubitemid 41297268)
47. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol. 2000;10:886-895. (Pubitemid 30647617)
48. Wu RS, Panusz HT, Hatch CL, Bonner WM. Histones and their modifications. CRC Crit Rev Biochem. 1986;20:201-263.
49. Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W. Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev. 2002;12:162-169. (Pubitemid 34219488)
50. Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem. 2000;275:9390-9395. (Pubitemid 30185164)
51. Podhorecka M, Skladanowski A, Bozko P. H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy. J Nucleic Acids. 2010; vol. 2010. pii: 920161.
52. Wen W, Zhu F, Zhang J, et al. MST1 promotes apoptosis through phosphorylation of histone H2AX. J Biol Chem. 2010;285:39108-39116.
53. Liu Y, Parry JA, Chin A, Duensing S, Duensing A. Soluble histone H2AX is induced by DNA replication stress and sensitizes cells to undergo apoptosis. Mol Cancer. 2008;7:61.
54. Lu C, Zhu F, Cho YY, et al. Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol Cell. 2006;23:121-132. (Pubitemid 43963445)
55. McLaughlin N, Annabi B, Bouzeghrane M, et al. The Survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (-)-epigallocatechin-3-gallate. Brain Res. 2006;1071:1-9. (Pubitemid 43255470)
56. Shirai K, Suzuki Y, Oka K, et al. Nuclear survivin expression predicts poorer prognosis in glioblastoma. J Neurooncol. 2009;91:353-358.
57. Gondi CS, Kandhukuri N, Dinh DH, Gujrati M, Rao JS. Down-regulation of uPAR and uPA activates caspase-mediated apoptosis and inhibits the PI3K/AKT pathway. Int J Oncol. 2007;31:19-27.
58. Svensson C, Part K, Kunnis-Beres K, Kaldmae M, Fernaeus SZ, Land T. Pro-survival effects of JNK and p38 MAPK pathways in LPS-induced activation of BV-2 cells. Biochem Biophys Res Commun. 2011;406:488-492.
59. Takahashi S, Ebihara A, Kajiho H, Kontani K, Nishina H, Katada T. RASSF7 negatively regulates pro-apoptotic JNK signaling by inhibiting the activity of phosphorylated-MKK7. Cell Death Differ. 2011;18:645-655.